Ascensia Diabetes Care News and Activities

Ascensia Diabetes Care is owned by KKR.

KKR is one of the...

• Forbes Global 2000 (#207);
• Fortune 500 (#156);
• Russell 3000;
• S&P 500;
• TOB Iconic 10,000.

KKR is a company listed under the stock ticker KKR (US).

KKR has a direct presence in 16 countries.

KKR has 101 subsidiaries including Aleris, Aleris Sweden and Ambea.

They are in:

• Healthcare16%
• Fund10%
• Other75%

Acquisition, funding and merger involving KKR.

• KKR has announced the acquisition of Crowe  (posted on June 18 2026).
• KKR has acquired Lionbridge Technologies (posted on April 8 2026).
• KKR has acquired Spectris (posted on December 5 2025).
• KKR has acquired Osttra (posted on October 10 2025).
• KKR has announced the acquisition of Spectris  (posted on August 28 2025).
• KKR has announced the acquisition of Osttra  (posted on April 15 2025).
• KKR has acquired Instructure (posted on November 14 2024).
• KKR has acquired The Parking Spot (posted on October 14 2024).
• KKR has acquired IQGeo (posted on October 1 2024).
• KKR has acquired Immedica Pharma (posted on September 25 2024).
• KKR has acquired Varsity Brands (posted on August 29 2024).
• KKR has acquired Avantus (posted on July 31 2024).
• KKR has acquired Marmic Fire (posted on July 29 2024).
• KKR has announced the acquisition of Instructure  (posted on July 29 2024).
• See more news about KKR Hide news involving KKR

View the org chart displaying its 9 main executives

Most searched biographies at Ascensia Diabetes Care

• Koichiro Sato, President and Chief Executive Officer (until Apr 1 ...
• Marieke Jansen, General Counsel and Chief Compliance Officer, EMEA...
• Peter Bodlund, President and Chief Executive Officer

Popular executive movements at Ascensia Diabetes Care

• Peter Bodlund who is Chief Operating Officer, will be promoted to President and Chief Executive Officer on Apr. 1, 2026  (posted on February 26 2026).
• Peter Bodlund who is Chief Operating Officer, will be promoted to President and Chief Executive Officer on Apr. 1, 2026  (posted on February 25 2026).

Popular executive movements at KKR

• Turia Lahlou, Managing Director of Credit and Markets, San Francisco, has left the company  (posted on June 4 2026).
• Ryan Stork, who is Partner, Business Operations will soon leave the company  (posted on January 14 2026).
• Ryan Stork who was Partner and Chief Operating Officer, becomes Partner, Business Operations  (posted on January 13 2026).

Click here to view some more movements at KKR

Create your alert
to follow the executive moves at Ascensia Diabetes Care.

KKR has 1,245 competitors including Thermo Fisher Scientific (United States (USA)), Cytiva (United States (USA)) and Medtronic (Ireland).

Popular M&A news in Medical Equipment

• CVC Capital Partners has announced the acquisition of WillowWood  (posted on June 18 2026).
• Spectrum Vascular has acquired Piccolo Medical (posted on June 17 2026).
• Medtronic has acquired Scientia Vascular (posted on June 14 2026).

Popular contacts in Medical Equipment

• Kweli Thompson - Executive Vice President and President, Neuroscience Portfolio at Medtronic
• Ivan Tornos - Chairman, President and Chief Executive Officer at Zimmer Biomet
• Marc Casper - Chairman of the Board, President and Chief Executive Officer at Thermo Fisher Scientific

Learn more about the Medical Equipment industry

Press releases by Ascensia Diabetes Care

• Ascensia | Press ReleasesBack ButtonSearch IconFilter Icon
• Ascensia | Press ReleasesBack ButtonSearch IconFilter Icon
• Ascensia | Press
• Ascensia | Press

Social media about Ascensia Diabetes Care

• Ascensia Diabetes Care on Wikipedia, Google News & Yahoo Finance
• Ascensia Diabetes Care on LinkedIn, X (Twitter) & YouTube